FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jörg Wischhusen

Research Profile

Anatomy

Disorders

Chemicals & Drugs

Physiology

Living Beings

Mouse

Co-author Network

Publications

TOP 3
Joachim Diessner; Johannes Dietl; Sebastian Häusler; Kathrin Becker; Valentin Bruttel; Miriam Pawlik; Roland Stein; Jörg Wischhusen; Arnd Hönig
Targeting breast cancer stem cells with HER2-specific antibodies and natural killer cells.
Mathias Krockenberger; Katharina Nürnberger; Jörg Wischhusen; Evi Horn; Peter Kranke; Johannes Dietl; Jörg Engel; Sebastian Häusler; Arnd Hönig
Macrophage migration-inhibitory factor levels in serum of patients with ovarian cancer correlates with poor prognosis.
Jens Claus Hahne; S F M Häussler; Arnd Honig; Susanne R Meyer; Sabine Elisabeth Segerer; U Walter; Jörg Wischhusen; Johannes Dietl; N Fujita; S Gambaryan; Jörg Engel
Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitro.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jörg Wischhusen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Joachim Diessner; Johannes Dietl; Sebastian Häusler; Kathrin Becker; Valentin Bruttel; Miriam Pawlik; Roland Stein; Jörg Wischhusen; Arnd Hönig
Targeting breast cancer stem cells with HER2-specific antibodies and natural killer cells.
American journal of cancer research 2013;3(2):211-20.
2012: Mathias Krockenberger; Katharina Nürnberger; Jörg Wischhusen; Evi Horn; Peter Kranke; Johannes Dietl; Jörg Engel; Sebastian Häusler; Arnd Hönig
Macrophage migration-inhibitory factor levels in serum of patients with ovarian cancer correlates with poor prognosis.
Anticancer research 2012;32(12):5233-8.
2012: Jens Claus Hahne; S F M Häussler; Arnd Honig; Susanne R Meyer; Sabine Elisabeth Segerer; U Walter; Jörg Wischhusen; Johannes Dietl; N Fujita; S Gambaryan; Jörg Engel
Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitro.
Oncology reports 2012;28(6):2023-8.
2012: Christoph P Beier; Ines Aschenbrenner; Ulrich Bogdahn; Valentin Bruttel; Athanassios Fragoulis; Peter Hau; Praveen Kumar; Katrin Lamszus; Petra Leukel; Katharina Meyer; Markus J Riemenschneider; Petra Rümmele; Jörg B Schulz; Rainer Spang; Joachim Weis; Jörg Wischhusen; Dagmar Beier
The cancer stem cell subtype determines immune infiltration of glioblastoma.
Stem cells and development 2012;21(15):2753-61.
2012: Nicole Hassold; Kristina Kempf; Hermann Einsele; Katharina Seystahl; Doris Urlaub; Carsten Watzl; Jörg Wischhusen; Michael Zekl; Ruth Seggewiss-Bernhardt
Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinib.
International journal of cancer. Journal international du cancer 2012;131(6):E916-27.
2012: Jörg Engel; Jens C Hahne; Sebastian F M Häusler; Mathias Krockenberger; Theresa Martens; Susanne Meyer; Sabine Segerer; Jörg Wischhusen; Johannes Dietl; Antonia Djakovic; Arnd Honig
Effects of lobaplatin as a single agent and in combination with TRAIL on the growth of triple-negative p53-mutated breast cancers in vitro.
Anti-cancer drugs 2012;23(4):426-36.
2011: Johannes Dietl; Jörg Wischhusen; Eva Geissinger
The fimbria/ovarian surface junction.
Human reproduction (Oxford, England) 2011;26(12):3494-5; author reply 3495.
2011: Johannes Dietl; Jörg Wischhusen; S F M Häusler
The post-reproductive Fallopian tube: better removed?
Human reproduction (Oxford, England) 2011;26(11):2918-24.
2011: Sebastian F M Häusler; Stefan Heuer; Arnd Hönig; Evi Horn; Markus Junker; Doris Kloor; Karl-Norbert Klotz; Hermann Kneitz; Mathias Krockenberger; Itsaso Montalbán del Barrio; Monika Ossadnik; Ahmed Adel Seida; Jenny Strohschein; P Anoop Chandran; Johannes Dietl; Jörg Engel; Birgitt Fischer; Jörg Wischhusen
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.
Cancer immunology, immunotherapy : CII 2011;60(10):1405-18.
2011: Michel Mittelbronn; Michael Platten; Michael Weller; Yvonne Dombrowski; Brigitte Frank; Patrick N Harter; Cornelia Zachskorn; Pia Zeiner; Jörg Wischhusen
Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression.
Acta neuropathologica 2011;122(3):353-65.
2011: Patrick Roth; Michael Weller; Jörg Wischhusen; P Anoop Chandran; Günter Eisele; Caroline Happold; Silvia Hofer; Andreas Keller
A specific miRNA signature in the peripheral blood of glioblastoma patients.
Journal of neurochemistry 2011;118(3):449-57.
2011: Johannes Dietl; Jörg Wischhusen
The forgotten fallopian tube.
Nature reviews. Cancer 2011;11(3):227; author reply 227.
2011: Jörg Engel; Tanja Schönhals; Sebastian Häusler; Mathias Krockenberger; Melanie Schmidt; Evi Horn; Frank Köster; Johannes Dietl; Jörg Wischhusen; Arnd Honig
Induction of programmed cell death by inhibition of AKT with the alkylphosphocholine perifosine in in vitro models of platinum sensitive and resistant ovarian cancers.
Archives of gynecology and obstetrics 2011;283(3):603-10.
2010: Sebastian F M Häusler; Monika Ossadnik; Evi Horn; Stefan Heuer; Johannes Dietl; Jörg Wischhusen
A cell-based luciferase-dependent assay for the quantitative determination of free extracellular adenosine with paracrine signaling activity.
Journal of immunological methods 2010;361(1-2):51-6.
2010: S F M Häusler; A Keller; P A Chandran; K Ziegler; K Zipp; S Heuer; M Krockenberger; Jörg Engel; Arnd Hönig; M Scheffler; Johannes Dietl; Jörg Wischhusen
Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening.
British journal of cancer 2010;103(5):693-700.
2010: Patrick Roth; Markus Junker; Isabel Tritschler; Michel Mittelbronn; Yvonne Dombrowski; Samuel N Breit; Ghazaleh Tabatabai; Wolfgang Wick; Michael Weller; Jörg Wischhusen
GDF-15 contributes to proliferation and immune escape of malignant gliomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(15):3851-9.
2010: Claudia Heidbrink; Sebastian F M Häusler; Mathias Buttmann; Monika Ossadnik; Herwig M Strik; Andreas Keller; Dorothea Buck; Evert Verbraak; Marjan van Meurs; Mathias Krockenberger; Matthias Mehling; Michel Mittelbronn; Jon D Laman; Heinz Wiendl; Jörg Wischhusen
Reduced cortisol levels in cerebrospinal fluid and differential distribution of 11beta-hydroxysteroid dehydrogenases in multiple sclerosis: implications for lesion pathogenesis.
Brain, behavior, and immunity 2010;24(6):975-84.
2010: Mathias Krockenberger; Jörg B Engel; Julia Kolb; Yvonne Dombrowsky; Sebastian F M Häusler; Nico Kohrenhagen; Johannes Dietl; Jörg Wischhusen; Arnd Honig
Macrophage migration inhibitory factor expression in cervical cancer.
Journal of cancer research and clinical oncology 2010;136(5):651-7.
2010: Claudio Lottaz; Dagmar Beier; Katharina Meyer; Praveen Kumar; Andreas Hermann; Johannes Schwarz; Markus Junker; Peter J Oefner; Ulrich Bogdahn; Jörg Wischhusen; Rainer Spang; Alexander Storch; Christoph P Beier
Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin.
Cancer research 2010;70(5):2030-40.
2009: Florian Reim; Yvonne Dombrowski; Cathrin Ritter; Mathias Buttmann; Sebastian Häusler; Monika Ossadnik; Mathias Krockenberger; Dagmar Beier; Christoph P Beier; Johannes Dietl; Jürgen C Becker; Arnd Hönig; Jörg Wischhusen
Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.
Cancer research 2009;69(20):8058-66.
2009: Jörg Engel; Tanja Schönhals; Claudia Weidler; Sebastian Häusler; Mathias Krockenberger; Lorenz Rieger; Johannes Dietl; Jörg Wischhusen; Arnd Honig
Tubulin inhibitor AEZS 112 inhibits the growth of experimental human ovarian and endometrial cancers irrespective of caspase inhibition.
Oncology reports 2009;22(2):361-7.
2009: Farid MENAA; Roland Houben; M Eyrich; E B Broecker; Jürgen C Becker; Jörg Wischhusen
Stem cells, melanoma and cancer stem cells: the good, the bad and the evil?
Giornale italiano di dermatologia e venereologia : organo ufficiale, Società italiana di dermatologia e sifilografia 2009;144(3):287-96.
2008: Anne Waschbisch; Sabine Wintterle; Hanns Lochmüller; Maggie C Walter; Jörg Wischhusen; Bernd C Kieseier; Heinz Wiendl
Human muscle cells express the costimulatory molecule B7-H3, which modulates muscle-immune interactions.
Arthritis and rheumatism 2008;58(11):3600-8.
2008: Jörg Engel; Arnd Honig; Tanja Schönhals; Claudia Weidler; Sebastian Häusler; Mathias Krockenberger; Thomas Grunewald; Yvonne Dombrowski; Lorenz Rieger; Johannes Dietl; Jörg Wischhusen
Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation.
European journal of obstetrics, gynecology, and reproductive biology 2008;141(1):64-9.
2008: Dagmar Beier; Stefanie Röhrl; Deepu R Pillai; Stefanie Schwarz; Leoni A Kunz-Schughart; Petra Leukel; Martin A Proescholdt; Alexander Brawanski; Ulrich Bogdahn; Ariane Trampe-Kieslich; Bernd Giebel; Jörg Wischhusen; Guido Reifenberger; Peter Hau; Christoph P Beier
Temozolomide preferentially depletes cancer stem cells in glioblastoma.
Cancer research 2008;68(14):5706-15.
2008: Roland Houben; Jörg Wischhusen; Farid MENAA; Peggy Synwoldt; David Schrama; Eva-Bettina Bröcker; Jürgen C Becker
Melanoma stem cells: targets for successful therapy?
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2008;6(7):541-6.
2008: Dagmar Beier; Jörg Wischhusen; Wolfgang Dietmaier; Peter Hau; Martin Proescholdt; Alexander Brawanski; Ulrich Bogdahn; Christoph P Beier
CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors.
Brain pathology (Zurich, Switzerland) 2008;18(3):370-7.
2008: Mathias Krockenberger; Yvonne Dombrowski; Claudia Weidler; Monika Ossadnik; Arnd Hönig; Sebastian Häusler; Heike Voigt; Jürgen C Becker; Lin Leng; Alexander Steinle; Michael Weller; Richard Bucala; Johannes Dietl; Jörg Wischhusen
Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(11):7338-48.
2008: L Weinmann; Jörg Wischhusen; Mark Demma; Ulrike Naumann; P Roth; B Dasmahapatra; Michael Weller
A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis.
Cell death and differentiation 2008;15(4):718-29.
2007: Jörg Wischhusen; Anne Waschbisch; Heinz Wiendl
Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?
Seminars in cancer biology 2007;17(6):459-68.
2007: Michel Mittelbronn; Perikles Simon; Christian Löffler; David Capper; Benedikt Bunz; Patrick Harter; Holger Schlaszus; Ariane Schleich; Ghazaleh Tabatabai; Benjamin Goeppert; Richard Meyermann; Michael Weller; Jörg Wischhusen
Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8+ cells.
Journal of neuroimmunology 2007;189(1-2):50-8.
2007: Johannes Dietl; Jörg Engel; Jörg Wischhusen
The role of regulatory T cells in ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(4):764-70.
2007: Dagmar Beier; Peter Hau; Martin A Proescholdt; Annette Lohmeier; Jörg Wischhusen; Peter J Oefner; Ludwig Aigner; Alexander Brawanski; Ulrich Bogdahn; Christoph P Beier
CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
Cancer research 2007;67(9):4010-5.
2006: Günter Eisele; Jörg Wischhusen; Michel Mittelbronn; Richard Meyermann; Inja Waldhauer; Alexander Steinle; Michael Weller; Manuel A Friese
TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells.
Brain : a journal of neurology 2006;129(Pt 9):2416-25.
2006: Ulrike Naumann; H Huang; Hartwig Wolburg; Jörg Wischhusen; Simone Weit; H Ohgaki; Michael Weller
PCTAIRE3: a putative mediator of growth arrest and death induced by CTS-1, a dominant-positive p53-derived synthetic tumor suppressor, in human malignant glioma cells.
Cancer gene therapy 2006;13(5):469-78.
2006: Patrick Roth; Steffen Aulwurm; Isabella Gekel; Dagmar Beier; Roxanne G Sperry; Michel Mittelbronn; Richard Meyermann; Kenneth D Beaman; Michael Weller; Jörg Wischhusen
Regeneration and tolerance factor: a novel mediator of glioblastoma-associated immunosuppression.
Cancer research 2006;66(7):3852-8.
2006: Steffen Aulwurm; Jörg Wischhusen; Manuel A Friese; Jannie Borst; Michael Weller
Immune stimulatory effects of CD70 override CD70-mediated immune cell apoptosis in rodent glioma models and confer long-lasting antiglioma immunity in vivo.
International journal of cancer. Journal international du cancer 2006;118(7):1728-35.
2006: Mirjam Hermisson; Andrea Klumpp; Wolfgang Wick; Jörg Wischhusen; Georg Nagel; Wynand Roos; Bernd Kaina; Michael Weller
O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells.
Journal of neurochemistry 2006;96(3):766-76.
2006: Bettina Schreiner; Joachim Voss; Jörg Wischhusen; Yvonne Dombrowski; Alexander Steinle; Hanns Lochmüller; Marinos C Dalakas; Arthur Melms; Heinz Wiendl
Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(1):118-20.
2005: Ghazaleh Tabatabai; Oliver Bähr; Robert Möhle; Ilker Eyüpoglu; Andreas M Boehmler; Jörg Wischhusen; Johannes Rieger; Ingmar Blümcke; Michael Weller; Wolfgang Wick
Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells.
Brain : a journal of neurology 2005;128(Pt 9):2200-11.
2005: Christoph P Beier; Jörg Wischhusen; Marc Gleichmann; Ellen Gerhardt; Ana Pekanovic; Andreas Krueger; Verdon Taylor; Ueli Suter; Peter H Krammer; Matthias Endres; Michael Weller; Jörg B Schulz
FasL (CD95L/APO-1L) resistance of neurons mediated by phosphatidylinositol 3-kinase-Akt/protein kinase B-dependent expression of lifeguard/neuronal membrane protein 35.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(29):6765-74.
2005: Jörg Wischhusen; Manuel A Friese; Michel Mittelbronn; Richard Meyermann; Michael Weller
HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo.
Journal of neuropathology and experimental neurology 2005;64(6):523-8.
2005: Jörg Wischhusen; Dagmar Schneider; Michel Mittelbronn; Richard Meyermann; Hartmut Engelmann; Gundram Jung; Heinz Wiendl; Michael Weller
Death receptor-mediated apoptosis in human malignant glioma cells: modulation by the CD40/CD40L system.
Journal of neuroimmunology 2005;162(1-2):28-42.
2005: Andreas Rimner; Samar Al Makdessi; Hicham Sweidan; Jörg Wischhusen; Björn Rabenstein; Khaula Shatat; Petra Mayer; Ioakim Spyridopoulos
Relevance and mechanism of oxysterol stereospecifity in coronary artery disease.
Free radical biology & medicine 2005;38(4):535-44.
2004: Ulrike Naumann; Jörg Wischhusen; Simone Weit; Johannes Rieger; Hartwig Wolburg; U Massing; Michael Weller
Alkylphosphocholine-induced glioma cell death is BCL-X(L)-sensitive, caspase-independent and characterized by massive cytoplasmic vacuole formation.
Cell death and differentiation 2004;11(12):1326-41.
2004: Martin Uhl; Steffen Aulwurm; Jörg Wischhusen; Markus Weiler; Jing Ying Ma; Ramona Almirez; Ruban Mangadu; Yu-Wang Liu; Michael Platten; Ulrich Herrlinger; Alison Murphy; Darren H Wong; Wolfgang Wick; Linda S Higgins; Michael Weller
SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Cancer research 2004;64(21):7954-61.
2004: Manuel A Friese; Jörg Wischhusen; Wolfgang Wick; Markus Weiler; Günter Eisele; Alexander Steinle; Michael Weller
RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.
Cancer research 2004;64(20):7596-603.
2003: Bettina Schreiner; Jörg Wischhusen; Meike Mitsdoerffer; Dagmar Schneider; Antje Bornemann; Arthur Melms; Eva Tolosa; Michael Weller; Heinz Wiendl
Expression of the B7-related molecule ICOSL by human glioma cells in vitro and in vivo.
Glia 2003;44(3):296-301.
2003: Jörg Wischhusen; Ulrike Naumann; H Ohgaki; F Rastinejad; Michael Weller
CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death.
Oncogene 2003;22(51):8233-45.
2003: Michael Platten; Katrin Eitel; Jörg Wischhusen; Johannes Dichgans; Michael Weller
Involvement of protein kinase Cdelta and extracellular signal-regulated kinase-2 in the suppression of microglial inducible nitric oxide synthase expression by N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast).
Biochemical pharmacology 2003;66(7):1263-70.
2003: Heinz Wiendl; Meike Mitsdoerffer; Valeska Hofmeister; Jörg Wischhusen; Elisabeth H Weiss; Johannes Dichgans; Hanns Lochmuller; Reinhard Hohlfeld; Arthur Melms; Michael Weller
The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy.
Brain : a journal of neurology 2003;126(Pt 1):176-85.
2002: Takao Watanabe; Huatao Huang; Mitsutoshi Nakamura; Jörg Wischhusen; Michael Weller; Paul Kleihues; Hiroko Ohgaki
Methylation of the p73 gene in gliomas.
Acta neuropathologica 2002;104(4):357-62.
2002: Mark S Hipp; Carmen Urbich; Petra Mayer; Jörg Wischhusen; Michael Weller; Michael Kracht; Ioakim Spyridopoulos
Proteasome inhibition leads to NF-kappaB-independent IL-8 transactivation in human endothelial cells through induction of AP-1.
European journal of immunology 2002;32(8):2208-17.
2002: Jörg Wischhusen; Gundram Jung; Ivan Radovanovic; Christoph P Beier; Joachim P Steinbach; Andreas Rimner; Huatao Huang; Jörg B Schulz; Hiroko Ohgaki; Adriano Aguzzi; Hans-Georg Rammensee; Michael Weller
Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma.
Cancer research 2002;62(9):2592-9.
2002: Heinz Wiendl; Meike Mitsdoerffer; Valeska Hofmeister; Jörg Wischhusen; Antje Bornemann; Richard Meyermann; Elisabeth H Weiss; Arthur Melms; Michael Weller
A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(9):4772-80.
2001: Michael Platten; Wolfgang Wick; Jörg Wischhusen; Michael Weller
N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) suppresses microglial inducible nitric oxide synthase (iNOS) expression and activity induced by interferon-gamma (IFN-gamma).
British journal of pharmacology 2001;134(6):1279-84.
2001: Ulrike Naumann; Simone Weit; Jörg Wischhusen; Michael Weller
Diva/Boo is a negative regulator of cell death in human glioma cells.
FEBS letters 2001;505(1):23-6.
2001: Andreas Rimner; Jörg Wischhusen; Ulrike Naumann; Marc Gleichmann; Joachim P Steinbach; Michael Weller
Identification by suppression subtractive hybridization of p21 as a radio-inducible gene in human glioma cells.
Anticancer research 2001;21(5):3505-8.
2001: Ioakim Spyridopoulos; Jörg Wischhusen; B Rabenstein; P Mayer; DI Axel; Kai-Uwe Fröhlich; Karl R Karsch
Alcohol enhances oxysterol-induced apoptosis in human endothelial cells by a calcium-dependent mechanism.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(3):439-44.
2001: F Schmidt; Johannes Rieger; Jörg Wischhusen; Ulrike Naumann; Michael Weller
Glioma cell sensitivity to topotecan: the role of p53 and topotecan-induced DNA damage.
European journal of pharmacology 2001;412(1):21-5.